Literature DB >> 31472908

Surgical Considerations of Hilar Cholangiocarcinoma.

Blaire Anderson1, M B Majella Doyle2.   

Abstract

Cholangiocarcinoma is an aggressive malignancy of the extrahepatic bile ducts. Hilar lesions are most common. Patients present with obstructive jaundice and intrahepatic bile duct dilation. Cross-sectional imaging reveals local, regional, and distant extent of disease, with direct cholangiography providing tissue for diagnosis. The consensus of a multidisciplinary committee dictates treatment. Resection of the extrahepatic bile duct and ipsilateral hepatic lobe with or without vascular resection and transplantation after neoadjuvant protocol are options for curative treatment. The goal of surgery is to remove the tumor with negative margins. Patients with inoperable tumors or metastatic disease are best served with palliative chemoradiotherapy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatic resection; Hilar cholangiocarcinoma; Liver transplantation; Vascular resection

Mesh:

Year:  2019        PMID: 31472908     DOI: 10.1016/j.soc.2019.06.003

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  9 in total

1.  NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance.

Authors:  Meng-Yu Zhang; Ming Luo; Kai He; Xian-Ming Xia; Jie-Ping Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  FXR expression in rats of hilar cholangiocarcinoma.

Authors:  Meng-Yu Zhang; Ming Luo; Jie-Ping Wang
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

3.  The Application of Three-Dimensional Visualization in Preoperative Evaluation of Portal Vein Invasion in Hilar Cholangiocarcinoma.

Authors:  Jun Zhang; Xiaochao Guo; He Wang; Jixin Zhang; Ping Liu; Qilu Qiao; Xin Wang
Journal:  Cancer Manag Res       Date:  2020-09-29       Impact factor: 3.989

Review 4.  Preoperative Management of Perihilar Cholangiocarcinoma.

Authors:  Ryan J Ellis; Kevin C Soares; William R Jarnagin
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

Review 5.  Approach to Resectable Biliary Cancers.

Authors:  Kimberly Washington; Flavio Rocha
Journal:  Curr Treat Options Oncol       Date:  2021-09-15

Review 6.  The Landmark Series: Hilar Cholangiocarcinoma.

Authors:  Kevin C Soares; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2021-04-07       Impact factor: 4.339

7.  Complete laparoscopic radical resection of hilar cholangiocarcinoma: technical aspects and long-term results from a single center.

Authors:  Jingdong Li; Yongfu Xiong; Gang Yang; Lixing Zhang; Muhammad Riaz; Jian Xu; Qiang Li; Zhaohui Tang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-07-16       Impact factor: 1.195

8.  Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup.

Authors:  Jian Zhao; Wei Zhang; Fu-Yu Li; Bin Song; Jun Zhang; Yun-Tian Chen; Wen-Jie Ma; Si-Yun Liu
Journal:  Cancer Manag Res       Date:  2020-12-22       Impact factor: 3.989

9.  Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.

Authors:  Jinglin Song; Xiaofeng Lei; Heng Lin; Haisu Dai; Xingchao Liu; Yan Jiang; Feng Hu; Yuancheng Li; Haining Fan; Leida Zhang; Zhiyu Chen; Chengcheng Zhang
Journal:  PLoS One       Date:  2022-04-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.